board members |
The Pathology Technology Australia volunteer Board of Directors is made up of recognised leaders across many areas of expertise. They represent the broad diversity of our membership and contribute significant amounts of time, talent, and energy to further the mission of our organisation.
Our Board of Directors has overall responsibility for Pathology Technology Australia's corporate governance. This includes establishing, reviewing and approving the strategic plan, policies, processes, procedures and practices, as well as assessing its own management and performance in order to regularly monitor and assess performance.
The Board of Pathology Technology Australia is elected by the membership from among the Corporate Representatives of Member Companies. Board Members are elected for a 2 year term and appoint a Chair, Deputy-Chair and Treasurer from among their number to serve a 1 year term. More information about the Board of Director’s role and responsibilities can be found in the Pathology Technology Australia Constitution.
Sebastian D’Angelo
Chair, Pathology Technology Australia General Manager, Laboratory Diagnostics Division, Siemens Healthineers – Australia & New Zealand. Sebastian has over 30 years’ experience within the Australian IVD industry, having worked as a medical scientist in public pathology laboratories before moving to senior roles at Chiron Diagnostics and Bayer Diagnostics and now at Siemens Healthcare Diagnostics. Sebastian holds a Bachelor of Applied Science (MLS) degree from RMIT University and a Master of Marketing degree from the Melbourne Business School. He is a Member of the Australian Institute of Company Directors. |
Karen MacLeod |
Mr Vito Trifilo |
John Crothers John Crothers is the Regional Director for Australia and New Zealand. Prior to the role in Australia, John was the Commercial Director for Asia Pacific and has also had several years in US Marketing. With over 25 years’ experience in the pathology industry in both the laboratory and IVD, the appreciation of the value of the industry in healthcare is a passion that John continues to pursue. John has a BSc(MLS) from RMIT and a Graduate Diploma in Business Administration from Swinburne University. |
David Basseal Vice Chair, Pathology Technology Australia Business Area Manager, Pathology Roche Diagnostics Australia Pty Ltd David Basseal has over 20 years industry experience in Life Sciences with 12 years specifically in In-Vitro Diagnostics. David commenced his career as a scientific researcher in the field of proteomics. He entered the commercial arena with Bio-Rad Laboratories Australia/New Zealand and held positions of increasing responsibility over a 7 year period. David then spent 9 years with Becton Dickinson (BD) leading numerous businesses within the diagnostics area. David final role at BD was the Business Director for Diagnostics for Australia/New Zealand at Becton Dickinson. Today David is with Roche Diagnostics Australia and holds the position of Business Area Manager for Pathology |
Tony Feneziani Tony has over 25 years commercial experience in the in vitro diagnostic and life sciences industries. During this time, Tony has undertaken a range of leadership roles including commercial operations, sales and marketing and business development. Tony’s current role at Merck also includes Country Leadership Team membership of the Merck Life Sciences operation in ANZ. |
Sally Hickman |
Rayden Rivett |
Antoniette Violo |